Lawmakers on the Punjab Assembly Public Accounts Committee-I launched a formal investigation into suspected financial corruption totaling Rs. 145 million regarding a pharmaceutical supply agreement. The government hospital deal was given to a local drug manufacturer while the prior administration was in power.
An audit document indicated that officials broke procurement regulations by selecting a business that did not possess the necessary background for providing pharmaceuticals.
The paperwork showed that the firm took twelve months to send the drugs, even though the agreement mandated delivery within a ninety-day window.
Committee members dismissed justifications from the Health Department during the meeting that blamed the coronavirus crisis for the hold-up.
PAC-I instructed the assigned investigator to look into how an unexperienced business managed to win the agreement and whether it met standard qualification rules.
Officials received orders from the committee to examine suspected improper favors given to the vendor and to pinpoint individuals accountable for breaking procurement guidelines.
The investigation will review the selection procedure, vendor qualifications, factors behind the tardy delivery, and the lack of penalties for missing the deadline.
Investigators will use the committee conclusions to figure out if rules were broken and fix blame for any verified infractions, though investigators have not proven guilt against the business or any person yet.
